128 related articles for article (PubMed ID: 9730426)
41. Preliminary results of a prospective randomized study of cyclosporine versus tacrolimus in the development of cardiac allograft vasculopathy at 1 year after heart transplantation.
Sánchez-Lázaro IJ; Almenar-Bonet L; Martínez-Dolz L; Buendía-Fuentes F; Navarro-Manchón J; Raso-Raso R; Agüero J; Salvador-Sanz A
Transplant Proc; 2010 Oct; 42(8):3199-200. PubMed ID: 20970650
[TBL] [Abstract][Full Text] [Related]
42. Transplantation for fulminant hepatic failure: comparing tacrolimus versus cyclosporine for immunosuppression and the outcome in elective transplants. European FK506 Liver Study Group.
Devlin J; Williams R
Transplantation; 1996 Nov; 62(9):1251-5. PubMed ID: 8932266
[TBL] [Abstract][Full Text] [Related]
43. [Small intestine transplantation. Experimental and clinical results].
Panis Y; Valleur P
Ann Chir; 1993; 47(7):645-58. PubMed ID: 7504899
[TBL] [Abstract][Full Text] [Related]
44. Comparison of low and high initial tacrolimus dosing in primary heart transplant recipients: a prospective European multicenter study.
Podesser BK; Rinaldi M; Yona NA; Pulpón LA; Villemot JP; Haverich A; Duveau D; Brandrup-Wognsen G; Gronda E; Costard-Jäckle A; Crespo-Leiro MG; Khazen CS; Viganó M; Segovia J; Mattei MF; Harringer W; Treilhaud M; Karason K; Mangiavacchi M; Laufer G
Transplantation; 2005 Jan; 79(1):65-71. PubMed ID: 15714171
[TBL] [Abstract][Full Text] [Related]
45. Histological patterns of rejection using oral microemulsified cyclosporine and tacrolimus (FK506) as monotherapy induction after orthotopic liver transplantation.
Chau TN; Quaglia A; Rolles K; Burroughs AK; Dhillon AP
Liver; 2001 Oct; 21(5):329-34. PubMed ID: 11589769
[TBL] [Abstract][Full Text] [Related]
46. Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation.
Spencer CM; Goa KL; Gillis JC
Drugs; 1997 Dec; 54(6):925-75. PubMed ID: 9421697
[TBL] [Abstract][Full Text] [Related]
47. Use of sublingual tacrolimus in lung transplant recipients.
Watkins KD; Boettger RF; Hanger KM; Leard LE; Golden JA; Hoopes CW; Singer JP
J Heart Lung Transplant; 2012 Feb; 31(2):127-32. PubMed ID: 22177691
[TBL] [Abstract][Full Text] [Related]
48. Association of SNPs with the efficacy and safety of immunosuppressant therapy after heart transplantation.
Sánchez-Lázaro I; Herrero MJ; Jordán-De Luna C; Bosó V; Almenar L; Rojas L; Martínez-Dolz L; Megías-Vericat JE; Sendra L; Miguel A; Poveda JL; Aliño SF
Pharmacogenomics; 2015; 16(9):971-9. PubMed ID: 26107754
[TBL] [Abstract][Full Text] [Related]
49. Two-year data from the European multicentre tacrolimus (FK506) liver study.
Williams R; Neuhaus P; Bismuth H; McMaster P; Pichlmayr R; Calne R; Otto G; Groth C
Transpl Int; 1996; 9 Suppl 1():S144-50. PubMed ID: 8959812
[TBL] [Abstract][Full Text] [Related]
50. Tacrolimus: in heart transplant recipients.
McCormack PL; Keating GM
Drugs; 2006; 66(17):2269-79; discussion 2280-2. PubMed ID: 17137409
[TBL] [Abstract][Full Text] [Related]
51. [The rescue effect of FK506 in refractory rejection after cardiac transplantation].
Hachida M; Hoshi H; Maeda T; Koyanagi H; Takahashi K; Yoyama N
Nihon Kyobu Geka Gakkai Zasshi; 1994 Oct; 42(10):1972-6. PubMed ID: 7528255
[TBL] [Abstract][Full Text] [Related]
52. One-year follow-up of an open-label trial of FK506 for primary kidney transplantation. A report of the U.S. Multicenter FK506 Kidney Transplant Group.
Vincenti F; Laskow DA; Neylan JF; Mendez R; Matas AJ
Transplantation; 1996 Jun; 61(11):1576-81. PubMed ID: 8669100
[TBL] [Abstract][Full Text] [Related]
53. Immunosuppression with tacrolimus early after orthotopic heart transplantation: a comparison of prograf and advagraf.
Ghodsizad A; Koch A; Ungerer MN; Bordel V; Zugck C; Ehlermann P; Doesch A; Karck M; Ruhparwar A
Heart Surg Forum; 2012 Dec; 15(6):E307-9. PubMed ID: 23262045
[TBL] [Abstract][Full Text] [Related]
54. Low-dose tacrolimus (FK506)-based immunosuppressive protocol in living donor renal transplantation.
Kokado Y; Takahara S; Kyo M; Ichimaru N; Jing-Ding W; Miki T; Okuyama A
Transpl Int; 1998; 11 Suppl 1():S60-4. PubMed ID: 9664945
[TBL] [Abstract][Full Text] [Related]
55. The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation.
Fung JJ; Eliasziw M; Todo S; Jain A; Demetris AJ; McMichael JP; Starzl TE; Meier P; Donner A
J Am Coll Surg; 1996 Aug; 183(2):117-25. PubMed ID: 8696542
[TBL] [Abstract][Full Text] [Related]
56. Efficacy and Safety of de Novo and Early Use of Extended-release Tacrolimus in Heart Transplantation.
González-Vílchez F; Lambert JL; Rangel D; Almenar L; de la Fuente JL; Palomo J; Díaz Molina B; Lage E; Sánchez Lázaro I; Vázquez de Prada JA
Rev Esp Cardiol (Engl Ed); 2018 Jan; 71(1):18-25. PubMed ID: 28545984
[TBL] [Abstract][Full Text] [Related]
57. Three-year follow-up of the European Multicenter Tacrolimus (FK506) Liver Study.
Pichlmayr R; Winkler M; Neuhaus P; McMaster P; Calne R; Otto G; Williams R; Groth CG; Bismuth H
Transplant Proc; 1997 Aug; 29(5):2499-502. PubMed ID: 9270825
[No Abstract] [Full Text] [Related]
58. Tacrolimus-based immunosuppression after liver transplantation: a randomised study comparing dual versus triple low-dose oral regimens.
Neuhaus P; Langrehr JM; Williams R; Calne RY; Pichlmayr R; McMaster P
Transpl Int; 1997; 10(4):253-61. PubMed ID: 9249934
[TBL] [Abstract][Full Text] [Related]
59. [Optimal therapeutic concentration of tacrolimus in adult patients undergoing reduced-intensity cord blood transplantation].
Nasu I; Ito T; Ino K; Minowa M; Furusawa M; Okuno Y; Uchida Y; Ishiwata K; Nakano N; Tsuji M; Takagi S; Yamamoto H; Matsuno N; Mori Y; Uchida N; Masuoka K; Wake A; Makino S; Miyakoshi S; Taniguchi S; Hayashi M
Gan To Kagaku Ryoho; 2011 Feb; 38(2):249-53. PubMed ID: 21372630
[TBL] [Abstract][Full Text] [Related]
60. Effects of cyclosporin, FK506, and rapamycin on graft-vessel disease.
Meiser BM; Billingham ME; Morris RE
Lancet; 1991 Nov; 338(8778):1297-8. PubMed ID: 1719321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
